Author

Devon Atkinson

Frederick National Laboratory for Cancer ResearchORCID 0000-0002-6675-1531Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Anish ThomasiD· 2 shared Laura BasseliD· 2 shared Rajaâ El MeskiniiD· 2 shared Zoë Weaver OhleriD· 2 shared Alejandro A. SchäfferiD· 1 shared Allison L. HuntiD· 1 shared Amanda DayiD· 1 shared Anna-Lena MeinhardtiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anish ThomasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer

Brett Schroeder, Jae Choi, Alejandro A. Schäffer, Michael Nirula, Yingying Cao, Yang Zhang, Anna-Lena Meinhardt, Hyeokjun Kwon, Hyerim Park, Sangin Lee, Hyo Jin Shin, Hee Geon Park, Hobin Yang, Sungyoul Hong, Parth Desai, , Anish Thomas

The paper identifies CLDN3 as a tumor-selective target in SCLC using proteogenomic analysis and validates its therapeutic potential with a monoclonal antibody.

bioRxiv · Jul 30, 2026 · PreprintCancer Biology

HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc- Driven Small Cell Lung Cancer

Azam Ghafoor, Linying Zhu, Zoë Weaver Ohler, Rajaâ El Meskini, Haoxuan Ying, Devon Atkinson, Amanda Day, Nathan Pate, Laura Bassel, Weixin Wang, Katherine R. Calvo, Lőrinc Sándor Pongor, Kanak Parmar, Yves G. Pommier, Anish Thomas, Yilun Sun

This study shows that HDAC inhibition with entinostat enhances immunotherapy response in SCLC by reprogramming tumor immunology and neuroendocrine status.

Molecular Cancer Therapeutics · Apr 30, 2026Peer-reviewedCancer Biology